Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 47.22M P/E 7.78 EPS this Y 33.30% Ern Qtrly Grth 422.40%
Income 485k Forward P/E 10.67 EPS next Y 400.00% 50D Avg Chg -4.00%
Sales 24.41M PEG - EPS past 5Y 100.07% 200D Avg Chg -52.00%
Dividend N/A Price/Book 1.02 EPS next 5Y - 52W High Chg -81.00%
Recommedations 2.00 Quick Ratio 8.02 Shares Outstanding 16.39M 52W Low Chg 26.00%
Insider Own 21.39% ROA -0.43% Shares Float 13.07M Beta 0.94
Inst Own 17.05% ROE 1.00% Shares Shorted/Prior 33.40K/24.73K Price 2.88
Gross Margin 57.61% Profit Margin 1.99% Avg. Volume 192,587 Target Price 6.67
Oper. Margin 40.84% Earnings Date May 9 Volume 26,692 Change 0.00%
About Sensus Healthcare, Inc.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Sensus Healthcare, Inc. News
04/18/24 Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
03/14/24 Sensus Healthcare to Participate in the 36th Annual Roth Conference
03/13/24 Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
02/25/24 3 Stocks to Buy That Are Up 100% or More in 2024
02/12/24 Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?
02/11/24 Sensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
02/09/24 Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call Transcript
02/09/24 Q4 2023 Sensus Healthcare Inc Earnings Call
02/08/24 Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates
02/08/24 Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
02/08/24 Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
02/06/24 Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
02/01/24 Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline
02/01/24 Sensus Healthcare Announces Retirement of Director Samuel O’Rear
02/01/24 Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?
01/30/24 Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
01/25/24 Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week
01/23/24 Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
11/10/23 Q3 2023 Sensus Healthcare Inc Earnings Call
11/09/23 Sensus Healthcare Reports Third Quarter 2023 Financial Results
SRTS Chatroom

User Image Stock_Titan Posted - 1 day ago

$SRTS Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024 https://www.stocktitan.net/news/SRTS/sensus-healthcare-to-host-first-quarter-2024-financial-results-and-8spwb9szpdqz.html

User Image john_iii Posted - 2 days ago

$SRTS update on the Fair deal program, another 3 RT recruitments. https://www.linkedin.com/posts/sensus-healthcare_hiringnow-joinourteam-sensushealthcare-activity-7184274914323959808-T2yK?utm_source=share&utm_medium=member_desktop

User Image mmrak Posted - 6 days ago

$SRTS still waiting for FDA on the transdermal device...

User Image GeoMo Posted - 2 weeks ago

$SRTS News?

User Image Presko8 Posted - 03/29/24

$CARA $ATHA $CLRB $SRTS patience could pay Big here

User Image Stradella Posted - 03/28/24

$SRTS It happened again today in AH, before a market holiday, go figure. Just over 2,000 shares near the end of the AH session. The dollar value isn't huge, but the head scratcher for me is why? If this trader waited until Monday, they probably could execute the trade at a better price. Hmmmmm... https://www.nasdaq.com/market-activity/stocks/srts/after-hours Have a good long weekend y'all!

User Image john_iii Posted - 03/26/24

$SRTS I think this is the first time Sensus is hiring directly RTs, the new sales model seems underway.

User Image Stradella Posted - 03/21/24

$SRTS Some interesting AH trade prints. It's not a lot of volume, but considering SRTS rarely trades after hours unless they put out an ER or other important PR. 4 prints over 3.90 and the last 2 at 3.95. https://www.nasdaq.com/market-activity/stocks/srts/after-hours

User Image BioGem Posted - 1 month ago

$SRTS Own a small, long position. I will hold for now despite the news that a competitor may be developing a similar product as: -Skin Cure's has not even been submitted to the FDA yet, and approval then launch won't happen till mid-2025. -The competitor can speculate which product is better, but only a head-to-head trial can definitively determine that matter. -The success rate with the traditional SRT is already in the 97-98% cure rate, if SRT-Vision/100+ has improved it a bit, we are nearing 100% cure rate, so how would a competitor product be truly better? -Finally, Skin Cure's product uses fancy imaging tech, which is a lot more expensive to manufacture, and not necessarily more efficacious medically, which allows Sensus to undercut them with a lower price to customers.

User Image Stock_Titan Posted - 1 month ago

$SRTS Sensus Healthcare to Participate in the 36th Annual Roth Conference https://www.stocktitan.net/news/SRTS/sensus-healthcare-to-participate-in-the-36th-annual-roth-er5gpsd8bf2e.html

User Image HuntingBenjmins Posted - 1 month ago

$SRTS Expect this to start going up….you’re welcome

User Image ParabolicVision Posted - 1 month ago

$SRTS Reassuring.

User Image Willie95 Posted - 1 month ago

$SRTS ...how long do you believe it will take SkinCure to get FDA approval?

User Image Presko8 Posted - 1 month ago

@jacksparo $SRTS $VIRX grelt Call man

User Image TheMarketsTheTarget Posted - 1 month ago

$SRTS LOL!!!! Which is it!!! Zero or manipulation

User Image TheMarketsTheTarget Posted - 1 month ago

$SRTS LMFAO

User Image mmrak Posted - 1 month ago

$SRTS the todays PR screams how surprised they were by the SkinCure actions...

User Image Stock_Titan Posted - 1 month ago

$SRTS Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting https://www.stocktitan.net/news/SRTS/sensus-healthcare-launches-fair-deal-agreement-for-its-srt-100-538dxdniqwnw.html

User Image ParabolicVision Posted - 1 month ago

$SRTS I'll nibble a little, starting today.

User Image HuntingBenjmins Posted - 1 month ago

$SRTS If you’ve ever had MOHS surgery, after reading about what their systems do…this has got a heck of a good future.

User Image ManosDeDiamante07 Posted - 1 month ago

$SRTS Easy money 💰

User Image Stradella Posted - 1 month ago

$SRTS We can only hope it was the company buying shares under the previously announced share buyback. https://sensus-dev.flywheelsites.com/sensus-healthcare-announces-new-3-million-share-repurchase-program/

User Image HuntingBenjmins Posted - 1 month ago

$SRTS Bravo to anyone that caught that ridiculous criminal dip earlier.

User Image Presko8 Posted - 1 month ago

$SRTS

User Image healthcareguru Posted - 1 month ago

$SRTS no reason other than a single seller dumping for this to be down so much…that will end and this will snap back…tactical long back to $4+

User Image healthcareguru Posted - 1 month ago

$SRTS report this guy @TheMarketsTheTarget for FUD mongering and spreading of misinformation in an attempt at market manipulation. 👇👇 @StocktwitsHelp

User Image TheMarketsTheTarget Posted - 1 month ago

$SRTS Very very

User Image HuntingBenjmins Posted - 1 month ago

$SRTS ok…what the bell is going on here?

User Image john_iii Posted - 1 month ago

$SRTS there has to be something cooking bad, 2 drops like these in two days.

User Image ManosDeDiamante07 Posted - 1 month ago

$SRTS Easy adds here

Analyst Ratings
HC Wainwright & Co. Buy Nov 13, 23
HC Wainwright & Co. Buy Aug 7, 23
HC Wainwright & Co. Buy May 4, 23
Alliance Global Partners Buy May 4, 23
HC Wainwright & Co. Buy Feb 10, 23
Alliance Global Partners Buy Feb 10, 23
Alliance Global Partners Buy Nov 4, 22
HC Wainwright & Co. Buy May 6, 22
HC Wainwright & Co. Buy Mar 3, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sardano Joseph C CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Sep 14 Buy 2.8773 10,000 28,773 1,175,293 09/18/23
Heinrich John Director Director May 11 Buy 2.86 10,000 28,600 79,940 05/31/23
Sardano Joseph C CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 09 Buy 2.99 25,000 74,750 1,155,293 05/11/23
O'Rear Samuel Director Director May 08 Buy 2.97 20,000 59,400 143,570 05/10/23
Sardano Michael PRESIDENT AND GENERA.. PRESIDENT AND GENERAL COUNSEL May 08 Buy 2.9950 1,000 2,995 56,774 05/10/23
Sardano Michael PRESIDENT AND GENERA.. PRESIDENT AND GENERAL COUNSEL Sep 13 Option 5.55 5,000 27,750 54,519 09/15/22
Sardano Michael PRESIDENT AND GENERA.. PRESIDENT AND GENERAL COUNSEL Sep 13 Sell 14.13 5,000 70,650 49,519 09/15/22
Sardano Joseph C CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Aug 09 Sell 14.11 158,412 2,235,193 1,171,881 08/11/22
McCall William H Director Director May 10 Sell 7.54 10,000 75,400 325,723 05/12/22
Sardano Joseph C CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Mar 10 Sell 10.16 133,356 1,354,897 1,330,293 03/11/22
Soro Nicolas CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Mar 09 Option 5.55 10,000 55,500 13,546 03/10/22
Soro Nicolas CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Mar 09 Sell 10.2 10,000 102,000 3,546 03/10/22
Rampolla Javier CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Mar 04 Option 5.5 9,000 49,500 52,049 03/08/22
Rampolla Javier CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Mar 04 Sell 9.42 9,000 84,780 61,049 03/08/22